172
Views
5
CrossRef citations to date
0
Altmetric
Original

Development of photostable gastro retentive formulation for nifedipine using low-density polypropylene microporous particles

, , &
Pages 409-416 | Received 14 Jul 2011, Accepted 02 Jan 2012, Published online: 01 Feb 2012

References

  • Anderson NH, Byard SJ. Photostability testing. Photostability of drugs and drug formulations, HH Tonnesen. CRS Press, Florida 2004; 137–60
  • Badve SS, Sher P, Korde A, Pawar AP. Development of hollow/porous calcium pectinate beads for floating pulsatile drug delivery. Eur J Biopharma 2007; 65: 85–93
  • Bayomi MA, Abanumay KA, Al-Angary AA. Effect of inclusion complexation with cyclodextrins on photostability of nifedipine in solid state. Int J Pharm 2001; 243: 107–17
  • Bechard SR, Quraishi O, Kwonga E. Film coating: Effect of titanium dioxide concentration and film thickness on the photostability of nifedipine. Int J Pharm 1992; 87: 133–9
  • Davis SS, Stockwell AF, Taylor MJ, Hardy JG, Whalley DR, Wilson CG, Bechgaard H, Christensen FN. The effect of density on the gastric emptying of single- and multiple-unit dosage forms. Pharm Res 1986; 3: 208–13
  • El-Gibaly I. Development and in vitro evaluation of novel floating chitosan microcapsules for oral use: Comparison with non-floating chitosan microspheres. Int J Pharm 2002; 249: 7–21
  • Foster TS, Hamann SR, Richards VR, Bryant PJ, Graves DA, McAllister RG. Nifedipine kinetics and bioavailability after single intravenous and oral doses in normal subjects. J Clin Pharmacol 1983; 23: 161–70
  • Hecq J, Deleers M, Fanara D, Vranckx H, Amighi K. Preparation and characterization of nanocrystals for solubility and dissolution rate enhancement of nifedipine. Int J Pharm 2005; 299: 167–77
  • Joseph NJ, Lakshmi S, Jayakrishnan A. A floating type oral dosage form for piroxicam based on hollow polycarbonate microspheres: In vitro and in vivo evaluation in rabbits. J Control Release 2002; 79: 71–9
  • Kawabe Y, Nakamuraa H, Hino E, Suzuki S. Photochemical stabilities of some dihydropyridine calcium-channel blockers in powdered pharmaceutical tablets. J Pharm Biomed Anal 2008; 47: 618–24
  • Kedzierewicz F, Thouvenot P, Lemut J, Etienne A, Hoffman M, Maincent P. Evaluation of peroral silicone dosage forms in humans by gamma-scintigraphy. J Cont Release 1999; 58: 195–205
  • Kerc J, Srcic S, Knez Z, Sencar-Bozic P. Micronization of drugs using supercritical carbon dioxide. Int J Pharm 1999; 182: 33–9
  • Kohri N, Katsumi M, Arita T, Shimono H, Nomura A, Yasuda H. Release characteristics of nifedipine sustained-release granules in vitro and in healthy subjects. Chem Pharm Bull 1987; 35: 2504–9
  • Kumaravelrajan R, Narayanan N, Suba V. Development and evaluation of controlled porosity osmotic pump for Nifedipine and Metoprolol combination. Lipids in Health and Disease 2011; 10: 51–63
  • Lee JH, Park TG, Choi HK. Development of oral drug delivery system using floating microspheres. J Microencapsul 1999; 16: 715–29
  • Li DX, Kim JO, Oh DH, Lee WS, Hong MJ, Kang JY, Choi JS, Woo JS, Yong CS, Choi HG. Development of nifedipine-loaded coated gelatin microcapsule as a long acting oral delivery. Arch Pharm Res 2009; 32: 127–32
  • Mitchell SA, Reynolds TD, Dasbach TP. A compaction process to enhance dissolution of poorly water soluble drugs using hydroxypropyl methylcellulose. Int J Pharm 2003; 250: 3–11
  • Morad M, Goldman YE, Trentham DR. Rapid photochemical inactivation of Ca2+ antagonists shows that Ca2+ entry directly activates contraction in frog heart. Nature 1983; 304: 635–8
  • Murad F. Drugs used for the treatment of angina: organic nitrates, calcium-channel blockers and adrenergic antagonists. The pharmacological basis of therapeutics, A Goodman Gilman, TW Rall, AS Nies, P Taylor. Pergamon, New York 1990; 764–83
  • Ponchel G, Touchard F, Duchene D, Peppas NA. Bioadhesive analysis of controlled release systems: I. Fracture and interprenetration analysis an poly(acrylic acid)-containing systems. J Control Release 1987; 5: 129–41
  • Scott DC. An assessment of reasonable tortuosity values. Pharm Res 2001; 18: 1797–800
  • Sharma S, Pawar AP. Low density multiparticulate system for pulsatile release of meloxicam. Int J Pharm 2006; 313: 150–8
  • Sher P, Ingavle G, Ponrathnam S, Pawar AP. Low-density porous carrier based conceptual drug delivery system. Micro Meso Mater 2007a; 102: 290–8
  • Sher P, Ingavle G, Ponrathnam S, Pawar AP. Low-density porous carrier: Drug adsorption and release study by response surface methodology using different solvents. Int J Pharm 2007b; 331: 72–83
  • Soppimath KS, Kulkarni AR, Aminabhavi TM. Development of hollow microspheres as floating controlled release system for cardiovascular drugs: Preparation and release characteristics. Drug Dev Ind Pharm 2001; 27: 507–15
  • Sorkin EM, Clissold SP, Brogden R. Nifedipine. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy in ischaemic heart disease, hypertension and related cardiovascular disorders. Drugs 1985; 30: 182–274
  • Teraoka R, Matsuda Y, Sugimoto I. Quantitative design for photostabilization of nifedipine by using titanium dioxide and/or tartrazine as colorants in model film coating systems. J Pharm Pharmacol 1988; 41: 293–7
  • Yoo HS. Preparation of biodegradable polymeric hollow microspheres using o/o/w emulsion stabilized by Labrafil. Colloids Surf B Biointerfaces 2006; 52: 47–51
  • Zajc N, Obreza A, Bele M, Srcic S. Physical properties and dissolution behaviour of nifedipine/mannitol solid dispersions prepared by hot melt method. Int J Pharm 2005; 291: 51–8
  • Zhao L, Yu-meng W, Yu Y, Wen-wu Z. Polymer blends used to prepare nifedipine loaded hollow microspheres for a floating-type oral drug delivery system: In Vitro evaluation. Arch Pharm Res 2010; 33: 443–50

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.